MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Marinus Pharmaceuticals Company Profile (NASDAQ:MRNS)

Consensus Ratings for Marinus Pharmaceuticals (NASDAQ:MRNS) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.50 (44.77% upside)

Analysts' Ratings History for Marinus Pharmaceuticals (NASDAQ:MRNS)
Show:
DateFirmActionRatingPrice TargetActions
8/5/2015OppenheimerReiterated RatingOutperform$12.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Janney Montgomery ScottReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015OppenheimerReiterated RatingOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014OppenheimerInitiated CoverageOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2014JMP SecuritiesInitiated CoverageOutperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Stifel NicolausInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Janney Montgomery ScottInitiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/27/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha